Monoclonal Antibody to Immunoglobulin G2a (IgG2a)    
    
            - UOM
 - FOB US$ 120.00 US$ 280.00 US$ 400.00 US$ 1,000.00 US$ 4,000.00
 - Quantity
 
Overview
Properties
- Product No.MAS094Mu21
 - Organism SpeciesMus musculus (Mouse) Same name, Different species.
 - ApplicationsTesting in progress
If the antibody is used in flow cytometry, please check FCM antibodies.
Research use only - DownloadInstruction Manual
 - Category
 
- SourceMonoclonal antibody preparation, Host Mouse
 - Ig Isotype IgG2b Kappa, Clone Number C2
 - PurificationProtein A + Protein G affinity chromatography
 - LabelNone
 - Immunogen CPS094Mu21-OVA Conjugated Immunoglobulin G2a (IgG2a)
 - Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
 - TraitsLiquid, Concentration 1mg/mL
 
Sign into your account
Share a new citation as an author
Upload your experimental result
Review

Contact us
Please fill in the blank.
Specifity
The antibody is a mouse monoclonal antibody raised against IgG2a. It has been selected for its ability to recognize IgG2a in immunohistochemical staining and western blotting.
Usage
Testing in progress
Storage
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Giveaways
Increment services
Citations
- Adipose Tissue-Derived Mesenchymal Stem Cell Modulates the Immune Response of Allergic Rhinitis in a Rat ModelPubmed: 30781605
 - Optimized GAPDH-truncated immunogen of Streptococcus equi elicits an enhanced immune response and provides effective protection in a mouse model33647714
 - The suppression of Brd4 inhibits peripheral plasma cell differentiation and exhibits therapeutic potential for systemic lupus erythematosus
 
